Cellectis (CLLS) Operating Leases (2018 - 2026)
Cellectis' Operating Leases came in at $23.82 million for Q2 2026, down 26.2% from $32.26 million a year earlier and down 8.2% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Operating Leases (2018 - 2026) Analysis & Trends
At the end of FY2025, Cellectis' Operating Leases was $27.73 million, down 19.0% from FY2024.
- Operating Leases has declined in each of the last five years, with a five-year compound annual growth rate of -18.2% (FY2020 to FY2025).
- Going back by year, Operating Leases was $34.25 million in FY2024 (-20.3%), $42.95 million in FY2023 (-13.0%), $49.36 million in FY2022 (-31.0%) and $71.53 million in FY2021 (-5.6%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases since Q4 2018.
- Year-over-year, Operating Leases has declined for 19 consecutive quarters, with an average decline of 19.7% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q3 2021 (growth of 9.5%), and the weakest in Q3 2023 (a decline of 31.1%).
- Business Quant data shows CLLS's Operating Leases at $25.95 million (Q1 2026), $27.73 million (Q4 2025) and $29.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Cellectis | 148.50 Mn | -604.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.82 Mn |
| Mar 31, 2026 | 25.95 Mn |
| Dec 31, 2025 | 27.73 Mn |
| Sep 30, 2025 | 29.25 Mn |
| Jun 30, 2025 | 32.26 Mn |
| Mar 31, 2025 | 33.14 Mn |
| Dec 31, 2024 | 34.25 Mn |
| Sep 30, 2024 | 36.68 Mn |
| Jun 30, 2024 | 38.36 Mn |
| Mar 31, 2024 | 40.59 Mn |
| Dec 31, 2023 | 42.95 Mn |
| Sep 30, 2023 | 43.82 Mn |
| Jun 30, 2023 | 46.16 Mn |
| Mar 31, 2023 | 48.29 Mn |
| Dec 31, 2022 | 49.36 Mn |
| Sep 30, 2022 | 63.59 Mn |
| Jun 30, 2022 | 66.59 Mn |
| Mar 31, 2022 | 69.74 Mn |
| Dec 31, 2021 | 71.53 Mn |
| Sep 30, 2021 | 73.73 Mn |
API Access
Cellectis Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();